These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 19786017)
1. Hypothermia prevents the development of ischemic proliferative retinopathy induced by severe perinatal asphyxia. Rey-Funes M; Ibarra ME; Dorfman VB; López EM; López-Costa JJ; Coirini H; Loidl CF Exp Eye Res; 2010 Jan; 90(1):113-20. PubMed ID: 19786017 [TBL] [Abstract][Full Text] [Related]
2. Hypothermia prevents gliosis and angiogenesis development in an experimental model of ischemic proliferative retinopathy. Rey-Funes M; Dorfman VB; Ibarra ME; Peña E; Contartese DS; Goldstein J; Acosta JM; Larráyoz IM; Martínez-Murillo R; Martínez A; Loidl CF Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2836-46. PubMed ID: 23471892 [TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL J Comp Neurol; 2007 Oct; 504(4):404-17. PubMed ID: 17663451 [TBL] [Abstract][Full Text] [Related]
4. Hypothermia prevents nitric oxide system changes in retina induced by severe perinatal asphyxia. Rey-Funes M; Ibarra ME; Dorfman VB; Serrano J; Fernández AP; Martínez-Murillo R; Martínez A; Coirini H; Rodrigo J; Loidl CF J Neurosci Res; 2011 May; 89(5):729-43. PubMed ID: 21337363 [TBL] [Abstract][Full Text] [Related]
5. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. McLeod DS; D'Anna SA; Lutty GA Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1918-32. PubMed ID: 9727415 [TBL] [Abstract][Full Text] [Related]
6. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. Taomoto M; McLeod DS; Merges C; Lutty GA Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091 [TBL] [Abstract][Full Text] [Related]
8. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396 [TBL] [Abstract][Full Text] [Related]
9. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833 [TBL] [Abstract][Full Text] [Related]
10. Methylene blue prevents retinal damage in an experimental model of ischemic proliferative retinopathy. Rey-Funes M; Larrayoz IM; Fernández JC; Contartese DS; Rolón F; Inserra PI; Martínez-Murillo R; López-Costa JJ; Dorfman VB; Martínez A; Loidl CF Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1011-9. PubMed ID: 26984891 [TBL] [Abstract][Full Text] [Related]
11. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Cunningham S; McColm JR; Wade J; Sedowofia K; McIntosh N; Fleck B Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4275-80. PubMed ID: 11095626 [TBL] [Abstract][Full Text] [Related]
12. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo. Yoo MH; Hyun HJ; Koh JY; Yoon YH Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4780-7. PubMed ID: 16303979 [TBL] [Abstract][Full Text] [Related]
13. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. Berkowitz BA; Penn JS Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):840-5. PubMed ID: 9538894 [TBL] [Abstract][Full Text] [Related]
14. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity. McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479 [TBL] [Abstract][Full Text] [Related]
15. Immunopathological studies on retinopathy of prematurity (ROP). Itoh H; Okuda T; Yamamoto M Kobe J Med Sci; 1984 Aug; 30(3-4):53-61. PubMed ID: 6210396 [No Abstract] [Full Text] [Related]
17. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of retinopathy of prematurity and possible preventive strategies. Fleck BW; McIntosh N Early Hum Dev; 2008 Feb; 84(2):83-8. PubMed ID: 18234458 [TBL] [Abstract][Full Text] [Related]
19. Potential role of microglia in retinal blood vessel formation. Checchin D; Sennlaub F; Levavasseur E; Leduc M; Chemtob S Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3595-602. PubMed ID: 16877434 [TBL] [Abstract][Full Text] [Related]
20. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Liu K; Akula JD; Falk C; Hansen RM; Fulton AB Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2639-47. PubMed ID: 16723481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]